Life Healthcare Group Holdings Limited

JSE:LHC Rapport sur les actions

Capitalisation boursière : R20.1b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Life Healthcare Group Holdings Gestion

Gestion contrôle des critères 4/4

Le PDG Life Healthcare Group Holdings' est Peter Wharton-Hood, nommé en Sep2020, a un mandat de 3.92 ans. La rémunération annuelle totale est ZAR 18.91M, composée du salaire de 46.4% et des bonus 53.6%, y compris les actions et options de la société. détient directement 0.18% des actions de la société, d'une valeur de ZAR 36.36M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.9 ans et 4.3 ans.

Informations clés

Peter Wharton-Hood

Directeur général

R18.9m

Rémunération totale

Pourcentage du salaire du PDG46.4%
Durée du mandat du directeur général3.9yrs
Propriété du PDG0.2%
Durée moyenne d'occupation des postes de direction3.9yrs
Durée moyenne du mandat des membres du conseil d'administration4.3yrs

Mises à jour récentes de la gestion

Recent updates

Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Aug 05
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

May 30
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Apr 20
Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Mar 18
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

Dec 24
Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Nov 24
We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

Nov 23
Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Sep 14
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Aug 15
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Jul 31
Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

May 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

Apr 28
Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

Feb 08
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Jan 25
There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Jan 08
With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Nov 28
Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Oct 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

Aug 16
Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Jul 20
We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

May 14
Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

Mar 21
How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

Analyse de la rémunération des PDG

Comment la rémunération de Peter Wharton-Hood a-t-elle évolué par rapport aux bénéfices de Life Healthcare Group Holdings?
DateRémunération totaleSalaireBénéfices de l'entreprise
Mar 31 2024n/an/a

R1b

Dec 31 2023n/an/a

R1b

Sep 30 2023R19mR9m

R1b

Mar 31 2023n/an/a

R1b

Dec 31 2022n/an/a

R1b

Sep 30 2022R18mR8m

R1b

Mar 31 2022n/an/a

R2b

Dec 31 2021n/an/a

R2b

Sep 30 2021R18mR8m

R2b

Mar 31 2021n/an/a

R629m

Dec 31 2020n/an/a

R668m

Sep 30 2020R8mR641k

R706m

Rémunération vs marché: La rémunération totale de Peter ($USD 1.07M ) est dans la moyenne des entreprises de taille similaire sur le marché ZA ($USD 1.13M ).

Rémunération et revenus: La rémunération de Peter a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Peter Wharton-Hood (58 yo)

3.9yrs

Titularisation

R18,907,000

Compensation

Mr. Peter G. Wharton-Hood, (BCom (Hons) (Wits), CA(SA), AMP (Harvard)), serves as the Group Chief Executive Officer at Life Healthcare Group Holdings since September 1, 2020 and also serves as its Executiv...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Peter Wharton-Hood
Group CEO & Executive Director3.9yrsR18.91m0.18%
ZAR 36.6m
Pieter van der Westhuizen
Group CFO & Executive Director11.2yrsR13.81m0.096%
ZAR 19.3m
Adam Pyle
Chief Strategy & Growth Officer and Executive Head of Investor Relationsno dataR10.37mpas de données
Craig Koekemoer
Chief Operations Officerless than a yearpas de donnéespas de données
Avanthi Parboosing
Chief People Officer3.4yrspas de donnéespas de données
Megan Naidoo
Chief Financial Officer of South Africa4.7yrspas de donnéespas de données
Joshila Ranchhod
Group Company Secretary3.4yrspas de donnéespas de données
Guy Blomfield
Non-Executive Director of Life UK6.2yrsR16.34mpas de données
Nick Burley
Non-Executive Director of Life UKno datapas de donnéespas de données

3.9yrs

Durée moyenne de l'emploi

56yo

Âge moyen

Gestion expérimentée: L'équipe de direction de LHC est considérée comme expérimentée (ancienneté moyenne 3.9 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Peter Wharton-Hood
Group CEO & Executive Directorno dataR18.91m0.18%
ZAR 36.6m
Pieter van der Westhuizen
Group CFO & Executive Director11.2yrsR13.81m0.096%
ZAR 19.3m
Lars Holmqvist
Independent Non-Executive Director2yrsR2.84mpas de données
Audrey Mothupi
Independent Non-Executive Director7.1yrsR1.03mpas de données
Mahlape Sello
Lead Independent Non-Executive Director7.1yrsR1.10mpas de données
Joel Netshitenzhe
Independent Non-Executive Director13.8yrsR852.00kpas de données
Caroline Henry
Independent Non-Executive Director2.9yrsR1.19mpas de données
Marian Jacobs
Independent Non-Executive Director10.6yrsR896.00kpas de données
Victor Litlhakanyane
Independent Non-Executive Chairman4.3yrsR2.10m0.00069%
ZAR 138.8k
Fulvio Tonelli
Independent Non-Executive Director1.3yrsR555.00kpas de données
Tebogo Moeketsi
Independent Non-Executive Director1.5yrsR627.00kpas de données
Jeanne Bolger
Independent Non-Executive Director2yrsR2.74mpas de données

4.3yrs

Durée moyenne de l'emploi

60.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de LHC sont considérés comme expérimentés (ancienneté moyenne 4.3 ans).